FREE PhD study and funding virtual fair REGISTER NOW FREE PhD study and funding virtual fair REGISTER NOW

pharma PhD Projects, Programmes & Scholarships

We have 10 pharma PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 10 pharma PhD Projects, Programmes & Scholarships

PhD saved successfully

Assessing risks of resistance to novel antimicrobials targeting Pseudomonas aeruginosa

Commercial partner: . Bactobio Ltd. , London. Antibiotic resistance has emerged as an important threat to human health, and there is a clear need to develop new drugs that are active against multi-drug resistant bacterial pathogens. Read more

EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME)

The CDT in Engineered Tissues for Discovery, Industry and Medicine is a partnership between the University of Glasgow, University of Birmingham, Aston University and National University of Ireland Galway. Read more

EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME)

The CDT in Engineered Tissues for Discovery, Industry and Medicine is a partnership between the University of Glasgow, University of Birmingham, Aston University and National University of Ireland Galway. Read more

EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME)

The CDT in Engineered Tissues for Discovery, Industry and Medicine is a partnership between the University of Glasgow, University of Birmingham, Aston University and National University of Ireland Galway. Read more

EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME)

The CDT in Engineered Tissues for Discovery, Industry and Medicine is a partnership between the University of Glasgow, University of Birmingham, Aston University and National University of Ireland Galway. Read more

Macrophage driven therapy resistance in AML: from macrophage subset characterisation to therapeutic targeting.

  Research Group: Molecular Mechanisms and Long Term Conditions
Reference. SHLS20065. Background. Acute Myeloid Leukaemia (AML) is a common blood cancer in adults; with its incidence increasing with age, AML cases are predicted to double by 2030. Read more
  • 1

Filtering Results